首页 > 最新文献

Molecular Metabolism最新文献

英文 中文
Esrra regulates Rplp1-mediated translation of lysosome proteins suppressed in metabolic dysfunction-associated steatohepatitis and reversed by alternate day fasting Esrra调节Rplp1介导的溶酶体蛋白翻译,在代谢功能障碍相关性脂肪性肝炎中受到抑制,并通过隔日禁食得到逆转。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-19 DOI: 10.1016/j.molmet.2024.101997
Madhulika Tripathi , Karine Gauthier , Reddemma Sandireddy , Jin Zhou , Priyanka Guptta , Suganya Sakthivel , Wei Wen Teo , Yadanar Than Naing , Kabilesh Arul , Keziah Tikno , Sung-Hee Park , Yajun Wu , Lijin Wang , Boon-Huat Bay , Lei Sun , Vincent Giguere , Pierce K.H. Chow , Sujoy Ghosh , Donald P. McDonnell , Paul M. Yen , Brijesh K. Singh

Objective

Currently, little is known about the mechanism(s) regulating global and specific protein translation during metabolic dysfunction-associated steatohepatitis (MASH; previously known as non-alcoholic steatohepatitis, NASH).

Methods

Unbiased label-free quantitative proteome, puromycin-labelling and polysome profiling were used to understand protein translation activity in vitro and in vivo.

Results

We observed a global decrease in protein translation during lipotoxicity in human primary hepatocytes, mouse hepatic AML12 cells, and livers from a dietary mouse model of MASH. Interestingly, proteomic analysis showed that Rplp1, which regulates ribosome and translation pathways, was one of the most downregulated proteins. Moreover, decreased Esrra expression and binding to the Rplp1 promoter, diminished Rplp1 gene expression during lipotoxicity. This, in turn, reduced global protein translation and Esrra/Rplp1-dependent translation of lysosome (Lamp2, Ctsd) and autophagy (sqstm1, Map1lc3b) proteins. Of note, Esrra did not increase its binding to these gene promoters or their gene transcription, confirming its regulation of their translation during lipotoxicity. Notably, hepatic Esrra-Rplp1-dependent translation of lysosomal and autophagy proteins also was impaired in MASH patients and liver-specific Esrra knockout mice. Remarkably, alternate day fasting induced Esrra-Rplp1-dependent expression of lysosomal proteins, restored autophagy, and reduced lipotoxicity, inflammation, and fibrosis in hepatic cell culture and in vivo models of MASH.

Conclusions

Esrra regulation of Rplp1-mediated translation of lysosome/autolysosome proteins was downregulated during MASH. Alternate day fasting activated this novel pathway and improved MASH, suggesting that Esrra and Rplp1 may serve as therapeutic targets for MASH. Our findings also provided the first example of a nuclear hormone receptor, Esrra, to not only regulate transcription but also protein translation, via induction of Rplp1.

目的:目前,人们对代谢功能障碍相关性脂肪性肝炎(MASH,以前称为非酒精性脂肪性肝炎,NASH)期间全局和特定蛋白质翻译的调节机制知之甚少:方法:采用无偏倚的无标记定量蛋白质组、嘌呤霉素标记和多聚体分析来了解体外和体内的蛋白质翻译活动:结果:我们观察到,在人类原代肝细胞、小鼠肝脏 AML12 细胞和 MASH 饮食模型小鼠肝脏中,脂肪毒性过程中蛋白质翻译全面减少。有趣的是,蛋白质组分析表明,调节核糖体和翻译途径的 Rplp1 是下调最多的蛋白质之一。此外,在脂肪毒性过程中,Esrra的表达和与Rplp1启动子的结合减少,从而降低了Rplp1基因的表达。这反过来又减少了全局蛋白质的翻译,以及溶酶体(Lamp2、Ctsd)和自噬(sqstm1、Map1lc3b)蛋白质依赖于Esrra/Rplp1的翻译。值得注意的是,Esrra 与这些基因启动子的结合及其基因转录并没有增加,这证实了它在脂肪毒性期间对这些基因翻译的调控作用。值得注意的是,在MASH患者和肝脏特异性Esrra基因敲除小鼠中,肝脏溶酶体和自噬蛋白的依赖性Esrra-Rplp1翻译也受到了影响。值得注意的是,在肝细胞培养和MASH体内模型中,隔日禁食诱导了溶酶体蛋白的Esrra-Rplp1依赖性表达,恢复了自噬,并降低了脂肪毒性、炎症和纤维化:结论:在MASH期间,Esrra对Rplp1介导的溶酶体/自溶酶体蛋白翻译的调控被下调。隔日禁食激活了这一新途径并改善了 MASH,这表明 Esrra 和 Rplp1 可作为 MASH 的治疗靶点。我们的研究结果还首次证明了核激素受体Esrra不仅能调节转录,还能通过诱导Rplp1调节蛋白质翻译。
{"title":"Esrra regulates Rplp1-mediated translation of lysosome proteins suppressed in metabolic dysfunction-associated steatohepatitis and reversed by alternate day fasting","authors":"Madhulika Tripathi ,&nbsp;Karine Gauthier ,&nbsp;Reddemma Sandireddy ,&nbsp;Jin Zhou ,&nbsp;Priyanka Guptta ,&nbsp;Suganya Sakthivel ,&nbsp;Wei Wen Teo ,&nbsp;Yadanar Than Naing ,&nbsp;Kabilesh Arul ,&nbsp;Keziah Tikno ,&nbsp;Sung-Hee Park ,&nbsp;Yajun Wu ,&nbsp;Lijin Wang ,&nbsp;Boon-Huat Bay ,&nbsp;Lei Sun ,&nbsp;Vincent Giguere ,&nbsp;Pierce K.H. Chow ,&nbsp;Sujoy Ghosh ,&nbsp;Donald P. McDonnell ,&nbsp;Paul M. Yen ,&nbsp;Brijesh K. Singh","doi":"10.1016/j.molmet.2024.101997","DOIUrl":"10.1016/j.molmet.2024.101997","url":null,"abstract":"<div><h3>Objective</h3><p>Currently, little is known about the mechanism(s) regulating global and specific protein translation during metabolic dysfunction-associated steatohepatitis (MASH; previously known as non-alcoholic steatohepatitis, NASH).</p></div><div><h3>Methods</h3><p>Unbiased label-free quantitative proteome, puromycin-labelling and polysome profiling were used to understand protein translation activity <em>in vitro</em> and <em>in vivo</em>.</p></div><div><h3>Results</h3><p>We observed a global decrease in protein translation during lipotoxicity in human primary hepatocytes, mouse hepatic AML12 cells, and livers from a dietary mouse model of MASH. Interestingly, proteomic analysis showed that Rplp1, which regulates ribosome and translation pathways, was one of the most downregulated proteins. Moreover, decreased Esrra expression and binding to the Rplp1 promoter, diminished Rplp1 gene expression during lipotoxicity. This, in turn, reduced global protein translation and Esrra/Rplp1-dependent translation of lysosome (Lamp2, Ctsd) and autophagy (sqstm1, Map1lc3b) proteins. Of note, Esrra did not increase its binding to these gene promoters or their gene transcription, confirming its regulation of their translation during lipotoxicity. Notably, hepatic Esrra-Rplp1-dependent translation of lysosomal and autophagy proteins also was impaired in MASH patients and liver-specific <em>Esrra</em> knockout mice. Remarkably, alternate day fasting induced Esrra-Rplp1-dependent expression of lysosomal proteins, restored autophagy, and reduced lipotoxicity, inflammation, and fibrosis in hepatic cell culture and <em>in vivo</em> models of MASH.</p></div><div><h3>Conclusions</h3><p>Esrra regulation of Rplp1-mediated translation of lysosome/autolysosome proteins was downregulated during MASH. Alternate day fasting activated this novel pathway and improved MASH, suggesting that Esrra and Rplp1 may serve as therapeutic targets for MASH. Our findings also provided the first example of a nuclear hormone receptor, Esrra, to not only regulate transcription but also protein translation, via induction of Rplp1.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101997"},"PeriodicalIF":7.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001285/pdfft?md5=81df0324e8a5b092148f5e4c0dd213eb&pid=1-s2.0-S2212877824001285-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic plasticity in a Pde6bSTOP/STOP retinitis pigmentosa mouse model following rescue Pde6bSTOP/STOP 视网膜色素变性小鼠模型获救后的代谢可塑性。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-19 DOI: 10.1016/j.molmet.2024.101994
Monika Ayten , Nundehui Díaz-Lezama , Hanaa Ghanawi , Felia C. Haffelder , Jacqueline Kajtna , Tobias Straub , Marco Borso , Axel Imhof , Stefanie M. Hauck , Susanne F. Koch

Objective

Retinitis pigmentosa (RP) is a hereditary retinal disease characterized by progressive photoreceptor degeneration, leading to vision loss. The best hope for a cure for RP lies in gene therapy. However, given that RP patients are most often diagnosed in the midst of ongoing photoreceptor degeneration, it is unknown how the retinal proteome changes as RP disease progresses, and which changes can be prevented, halted, or reversed by gene therapy.

Methods

Here, we used a Pde6b-deficient RP gene therapy mouse model and performed untargeted proteomic analysis to identify changes in protein expression during degeneration and after treatment.

Results

We demonstrated that Pde6b gene restoration led to a novel form of homeostatic plasticity in rod phototransduction which functionally compensates for the decreased number of rods. By profiling protein levels of metabolic genes and measuring metabolites, we observed an upregulation of proteins associated with oxidative phosphorylation in mutant and treated photoreceptors.

Conclusion

In conclusion, the metabolic demands of the retina differ in our Pde6b-deficient RP mouse model and are not rescued by gene therapy treatment. These findings provide novel insights into features of both RP disease progression and long-term rescue with gene therapy.

视网膜色素变性(RP)是一种遗传性视网膜疾病,其特点是进行性感光细胞变性,导致视力丧失。治愈视网膜色素变性症的最大希望在于基因治疗。然而,鉴于RP患者通常是在感光细胞不断变性的过程中被诊断出来的,因此确定视网膜蛋白质组是如何随着RP疾病的进展而变化的,并确定哪些变化可以通过基因疗法来预防、阻止或逆转是非常重要的。在这里,我们使用了 Pde6b 缺失的 RP 基因治疗小鼠模型,并证明了 Pde6b 基因的恢复会导致视杆细胞光传导中一种新形式的同态可塑性,从而在功能上补偿视杆细胞数量的减少。通过分析代谢基因的蛋白质水平和测量代谢物,我们观察到在突变体和接受治疗的感光体中,与氧化磷酸化相关的蛋白质上调。因此,在我们的 Pde6b 缺失型 RP 小鼠模型中,视网膜的新陈代谢需求是不同的,而且不会因基因治疗而得到缓解。这些发现为了解 RP 疾病进展和基因治疗长期挽救的特征提供了新的视角。
{"title":"Metabolic plasticity in a Pde6bSTOP/STOP retinitis pigmentosa mouse model following rescue","authors":"Monika Ayten ,&nbsp;Nundehui Díaz-Lezama ,&nbsp;Hanaa Ghanawi ,&nbsp;Felia C. Haffelder ,&nbsp;Jacqueline Kajtna ,&nbsp;Tobias Straub ,&nbsp;Marco Borso ,&nbsp;Axel Imhof ,&nbsp;Stefanie M. Hauck ,&nbsp;Susanne F. Koch","doi":"10.1016/j.molmet.2024.101994","DOIUrl":"10.1016/j.molmet.2024.101994","url":null,"abstract":"<div><h3>Objective</h3><p>Retinitis pigmentosa (RP) is a hereditary retinal disease characterized by progressive photoreceptor degeneration, leading to vision loss. The best hope for a cure for RP lies in gene therapy. However, given that RP patients are most often diagnosed in the midst of ongoing photoreceptor degeneration, it is unknown how the retinal proteome changes as RP disease progresses, and which changes can be prevented, halted, or reversed by gene therapy.</p></div><div><h3>Methods</h3><p>Here, we used a <em>Pde6b</em>-deficient RP gene therapy mouse model and performed untargeted proteomic analysis to identify changes in protein expression during degeneration and after treatment.</p></div><div><h3>Results</h3><p>We demonstrated that <em>Pde6b</em> gene restoration led to a novel form of homeostatic plasticity in rod phototransduction which functionally compensates for the decreased number of rods. By profiling protein levels of metabolic genes and measuring metabolites, we observed an upregulation of proteins associated with oxidative phosphorylation in mutant and treated photoreceptors.</p></div><div><h3>Conclusion</h3><p>In conclusion, the metabolic demands of the retina differ in our <em>Pde6b</em>-deficient RP mouse model and are not rescued by gene therapy treatment. These findings provide novel insights into features of both RP disease progression and long-term rescue with gene therapy.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"88 ","pages":"Article 101994"},"PeriodicalIF":7.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221287782400125X/pdfft?md5=6010579f47431b45363c3e5b7663bbf8&pid=1-s2.0-S221287782400125X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The homeodomain transcription factor Six3 regulates hypothalamic Pomc expression and its absence from POMC neurons induces hyperphagia and mild obesity in male mice 同源结构域转录因子 Six3 调节下丘脑 Pomc 的表达,缺失 POMC 神经元会诱导雄性小鼠食欲亢进和轻度肥胖
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-16 DOI: 10.1016/j.molmet.2024.101993
Hui Yu , Angelika Chiang , Marcelo Rubinstein , Malcolm J. Low

Objective

Proopiomelanocortin (POMC) neurons release potent anorexigenic neuropeptides, which suppress food intake and enhance energy expenditure via melanocortin receptors. Although the importance of central melanocortin in physiological regulation is well established, the underlying genetic mechanisms that define the functional identity of melanocortin neurons and maintain hypothalamic Pomc expression remain to be fully determined. In this study, we investigate the functional significance of Six3, a transcriptional regulator notably expressed in embryonic and adult mouse POMC neurons, in the regulation of hypothalamic Pomc expression and downstream physiological consequences.

Methods

We first evaluated the expression of Six3 in the developing and adult hypothalamus by double fluorescence in situ hybridization. Next, we assessed POMC immunoreactivity in mutant mice selectively lacking Six3 from Pomc-expressing neurons and quantified Pomc mRNA levels in a tamoxifen-inducible Six3 knockout mouse model activated at embryonic E9.5 days. We also determined glucose and insulin sensitivity, daily food intake, body composition and body weight in adult male and female mice lacking Six3 specifically from POMC neurons. Lastly, we assessed the physiological consequences of ablating Six3 from POMC neurons in adult mice.

Results

Six3 and Pomc were co-expressed in mouse hypothalamic neurons during development and adulthood. Mouse embryos deficient in Six3 showed reduced Pomc expression in the developing hypothalamus. Targeted deletion of Six3 specifically from POMC neurons resulted in decreased hypothalamic Pomc expression, increased daily food intake, enhanced glucose sensitivity and mild obesity in male but not in female mice. Finally, conditional removal of Six3 from POMC neurons in adult mice led to a reduction in hypothalamic POMC immunoreactivity with no significant effects in body weight or food intake.

Conclusions

Altogether, our results demonstrate that Six3 plays an essential role in the early establishment of POMC neuron identity and the maintenance of physiological levels of hypothalamic Pomc expression. In addition, our study demonstrates that the functional significance of Six3 expression in POMC neurons is sexually dimorphic and age-dependent.

目的前黑皮质素(POMC)神经元释放强效厌食神经肽,通过黑皮质素受体抑制食物摄入并增强能量消耗。尽管中枢黑皮质素在生理调节中的重要性已得到公认,但确定黑皮质素神经元功能特性和维持下丘脑 Pomc 表达的潜在遗传机制仍有待完全确定。在本研究中,我们研究了在胚胎和成年小鼠 POMC 神经元中显著表达的转录调节因子 Six3 在调控下丘脑 Pomc 表达及其下游生理后果中的功能意义。接下来,我们评估了选择性缺乏Pomc表达神经元中Six3的突变小鼠的POMC免疫反应,并量化了在胚胎E9.5天激活的他莫昔芬诱导的Six3基因敲除小鼠模型中的Pomc mRNA水平。我们还测定了特异性从 POMC 神经元中缺失 Six3 的成年雄性和雌性小鼠的葡萄糖和胰岛素敏感性、每日食物摄入量、身体成分和体重。最后,我们评估了从成年小鼠的 POMC 神经元中消减 Six3 的生理后果。缺乏Six3的小鼠胚胎在发育中的下丘脑中Pomc表达减少。从 POMC 神经元中特异性靶向删除 Six3 会导致雄性小鼠下丘脑 Pomc 表达减少、每日食物摄入量增加、葡萄糖敏感性增强以及轻度肥胖,但雌性小鼠不会。最后,有条件地从成年小鼠的 POMC 神经元中移除 Six3 会导致下丘脑 POMC 免疫活性降低,但对体重或食物摄入量没有显著影响。此外,我们的研究还证明了 Six3 在 POMC 神经元中表达的功能意义具有性别双态性和年龄依赖性。
{"title":"The homeodomain transcription factor Six3 regulates hypothalamic Pomc expression and its absence from POMC neurons induces hyperphagia and mild obesity in male mice","authors":"Hui Yu ,&nbsp;Angelika Chiang ,&nbsp;Marcelo Rubinstein ,&nbsp;Malcolm J. Low","doi":"10.1016/j.molmet.2024.101993","DOIUrl":"10.1016/j.molmet.2024.101993","url":null,"abstract":"<div><h3>Objective</h3><p>Proopiomelanocortin (POMC) neurons release potent anorexigenic neuropeptides, which suppress food intake and enhance energy expenditure via melanocortin receptors. Although the importance of central melanocortin in physiological regulation is well established, the underlying genetic mechanisms that define the functional identity of melanocortin neurons and maintain hypothalamic <em>Pomc</em> expression remain to be fully determined. In this study, we investigate the functional significance of <em>Six3,</em> a transcriptional regulator notably expressed in embryonic and adult mouse POMC neurons, in the regulation of hypothalamic <em>Pomc</em> expression and downstream physiological consequences.</p></div><div><h3>Methods</h3><p>We first evaluated the expression of <em>Six3</em> in the developing and adult hypothalamus by double fluorescence <em>in situ</em> hybridization. Next, we assessed POMC immunoreactivity in mutant mice selectively lacking <em>Six3</em> from <em>Pomc</em>-expressing neurons and quantified <em>Pomc</em> mRNA levels in a tamoxifen-inducible <em>Six3</em> knockout mouse model activated at embryonic E9.5 days. We also determined glucose and insulin sensitivity, daily food intake, body composition and body weight in adult male and female mice lacking <em>Six3</em> specifically from POMC neurons. Lastly, we assessed the physiological consequences of ablating <em>Six3</em> from POMC neurons in adult mice.</p></div><div><h3>Results</h3><p><em>Six3</em> and <em>Pomc</em> were co-expressed in mouse hypothalamic neurons during development and adulthood. Mouse embryos deficient in <em>Six3</em> showed reduced <em>Pomc</em> expression in the developing hypothalamus. Targeted deletion of <em>Six3</em> specifically from POMC neurons resulted in decreased hypothalamic <em>Pomc</em> expression, increased daily food intake, enhanced glucose sensitivity and mild obesity in male but not in female mice. Finally, conditional removal of <em>Six3</em> from POMC neurons in adult mice led to a reduction in hypothalamic POMC immunoreactivity with no significant effects in body weight or food intake.</p></div><div><h3>Conclusions</h3><p>Altogether, our results demonstrate that <em>Six3</em> plays an essential role in the early establishment of POMC neuron identity and the maintenance of physiological levels of hypothalamic <em>Pomc</em> expression. In addition, our study demonstrates that the functional significance of <em>Six3</em> expression in POMC neurons is sexually dimorphic and age-dependent.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101993"},"PeriodicalIF":7.0,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001248/pdfft?md5=e1f7da9c342a933d0153229da82b53ed&pid=1-s2.0-S2212877824001248-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141697099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axis 膳食中链脂肪酸通过激活 CREBH-FGF21 轴减少肝脏脂肪堆积
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-15 DOI: 10.1016/j.molmet.2024.101991
Ye Cao , Masaya Araki , Yoshimi Nakagawa , Luisa Deisen , Annemarie Lundsgaard , Josephine M. Kanta , Stephanie Holm , Kornelia Johann , Jens Christian Brings Jacobsen , Markus Jähnert , Annette Schürmann , Bente Kiens , Christoffer Clemmensen , Hitoshi Shimano , Andreas M. Fritzen , Maximilian Kleinert

Objective

Dietary medium-chain fatty acids (MCFAs), characterized by chain lengths of 8–12 carbon atoms, have been proposed to have beneficial effects on glucose and lipid metabolism, yet the underlying mechanisms remain elusive. We hypothesized that MCFA intake benefits metabolic health by inducing the release of hormone-like factors.

Methods

The effects of chow diet, high-fat diet rich in long-chain fatty acids (LCFA HFD) fed ad libitum or pair-fed to a high-fat diet rich in MCFA (MCFA HFD) on glycemia, hepatic gene expression, circulating fibroblast growth factor 21 (FGF21), and liver fat content in both wildtype and Fgf21 knockout mice were investigated. The impact of a single oral dose of an MCFA-rich oil on circulating FGF21 and hepatic Fgf21 mRNA expression was assessed. In flag-tagged Crebh knockin mice and liver-specific Crebh knockout mice, fed LCFA HFD or MCFA HFD, active hepatic CREBH and hepatic Fgf21 mRNA abundance were determined, respectively.

Results

MCFA HFD improves glucose tolerance, enhances glucose clearance into brown adipose tissue, and prevents high-fat diet-induced hepatic steatosis in wildtype mice. These benefits are associated with increased liver expression of CREBH target genes (Apoa4 and Apoc2), including Fgf21. Both acute and chronic intake of dietary MCFAs elevate circulating FGF21. Augmented hepatic Fgf21 mRNA following MCFA HFD intake is accompanied by higher levels of active hepatic CREBH; and MCFA-induced hepatic Fgf21 expression is blocked in mice lacking Crebh. Notably, while feeding male and female Fgf21 wildtype mice MCFA HFD results in reduced liver triacylglycerol (TG) levels, this liver TG-lowering effect is blunted in Fgf21 knockout mice fed MCFA HFD. The reduction in liver TG levels observed with MCFA HFD was independent of weight loss.

Conclusions

Dietary MCFAs reduce liver fat accumulation via activation of a CREBH-FGF21 signaling axis.

目的:膳食中链脂肪酸(MCFAs)的特点是链长为 8 至 12 个碳原子,它被认为对葡萄糖和脂质代谢具有有益影响,但其潜在机制仍难以捉摸。我们假设,摄入 MCFA 可通过诱导类激素因子的释放而有益于代谢健康:方法:我们研究了野生型小鼠和 Fgf21 基因敲除小鼠自由采食杂粮、富含长链脂肪酸的高脂饮食(LCFA HFD)或与富含 MCFA 的高脂饮食(MCFA HFD)配对饲喂对血糖、肝脏基因表达、循环成纤维细胞生长因子 21(FGF21)和肝脏脂肪含量的影响。评估了单次口服富含 MCFA 的油类对循环 FGF21 和肝脏 Fgf21 mRNA 表达的影响。在饲喂 LCFA HFD 或 MCFA HFD 的旗标 Crebh 基因敲除小鼠和肝脏特异性 Crebh 基因敲除小鼠中,分别测定了肝脏 CREBH 活性和肝脏 Fgf21 mRNA 丰度:结果:MCFA HFD能改善野生型小鼠的葡萄糖耐量,提高葡萄糖在棕色脂肪组织中的清除率,并防止高脂饮食引起的肝脏脂肪变性。这些益处与肝脏中 CREBH 靶基因(Apoa4 和 Apoc2)(包括 Fgf21)的表达增加有关。急性和慢性摄入膳食 MCFAs 都会升高循环中的 FGF21。摄入 MCFA HFD 后,肝脏 Fgf21 mRNA 增高,同时肝脏 CREBH 活性水平升高;在缺乏 Crebh 的小鼠中,MCFA 诱导的肝脏 Fgf21 表达受阻。值得注意的是,给雄性和雌性 Fgf21 野生型小鼠喂食 MCFA HFD 会导致肝脏三酰甘油(TG)水平降低,而在喂食 MCFA HFD 的 Fgf21 基因敲除小鼠中,这种降低肝脏 TG 的作用被削弱。膳食 MCFA HFD 对肝脏 TG 水平的降低与体重下降无关:结论:膳食 MCFA 可通过激活 CREBH-FGF21 信号轴减少肝脏脂肪积累。
{"title":"Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axis","authors":"Ye Cao ,&nbsp;Masaya Araki ,&nbsp;Yoshimi Nakagawa ,&nbsp;Luisa Deisen ,&nbsp;Annemarie Lundsgaard ,&nbsp;Josephine M. Kanta ,&nbsp;Stephanie Holm ,&nbsp;Kornelia Johann ,&nbsp;Jens Christian Brings Jacobsen ,&nbsp;Markus Jähnert ,&nbsp;Annette Schürmann ,&nbsp;Bente Kiens ,&nbsp;Christoffer Clemmensen ,&nbsp;Hitoshi Shimano ,&nbsp;Andreas M. Fritzen ,&nbsp;Maximilian Kleinert","doi":"10.1016/j.molmet.2024.101991","DOIUrl":"10.1016/j.molmet.2024.101991","url":null,"abstract":"<div><h3>Objective</h3><p>Dietary medium-chain fatty acids (MCFAs), characterized by chain lengths of 8–12 carbon atoms, have been proposed to have beneficial effects on glucose and lipid metabolism, yet the underlying mechanisms remain elusive. We hypothesized that MCFA intake benefits metabolic health by inducing the release of hormone-like factors.</p></div><div><h3>Methods</h3><p>The effects of chow diet, high-fat diet rich in long-chain fatty acids (LCFA HFD) fed <em>ad libitum</em> or pair-fed to a high-fat diet rich in MCFA (MCFA HFD) on glycemia, hepatic gene expression, circulating fibroblast growth factor 21 (FGF21), and liver fat content in both wildtype and <em>Fgf21</em> knockout mice were investigated. The impact of a single oral dose of an MCFA-rich oil on circulating FGF21 and hepatic <em>Fgf21</em> mRNA expression was assessed. In flag-tagged <em>Crebh</em> knockin mice and liver-specific <em>Crebh</em> knockout mice, fed LCFA HFD or MCFA HFD, active hepatic CREBH and hepatic <em>Fgf21</em> mRNA abundance were determined, respectively.</p></div><div><h3>Results</h3><p>MCFA HFD improves glucose tolerance, enhances glucose clearance into brown adipose tissue, and prevents high-fat diet-induced hepatic steatosis in wildtype mice. These benefits are associated with increased liver expression of CREBH target genes (<em>Apoa4</em> and <em>Apoc2</em>), including <em>Fgf21</em>. Both acute and chronic intake of dietary MCFAs elevate circulating FGF21. Augmented hepatic <em>Fgf21</em> mRNA following MCFA HFD intake is accompanied by higher levels of active hepatic CREBH; and MCFA-induced hepatic <em>Fgf21</em> expression is blocked in mice lacking <em>Crebh</em>. Notably, while feeding male and female <em>Fgf21</em> wildtype mice MCFA HFD results in reduced liver triacylglycerol (TG) levels, this liver TG-lowering effect is blunted in <em>Fgf21</em> knockout mice fed MCFA HFD. The reduction in liver TG levels observed with MCFA HFD was independent of weight loss.</p></div><div><h3>Conclusions</h3><p>Dietary MCFAs reduce liver fat accumulation via activation of a CREBH-FGF21 signaling axis.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101991"},"PeriodicalIF":7.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001224/pdfft?md5=52ef2cbb83387512b81a39ae57f11b35&pid=1-s2.0-S2212877824001224-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice 肝吸虫、金黄色葡萄球菌和肺炎双球菌的实验性定植不会影响野生型 SOPF 小鼠对高脂饮食或增量蛋白类似物的代谢反应。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-15 DOI: 10.1016/j.molmet.2024.101992
Margit Wunderlich , Manuel Miller , Bärbel Ritter , Ronan Le Gleut , Hannah Marchi , Monir Majzoub-Altweck , Patrick J. Knerr , Jonathan D. Douros , Timo D. Müller , Markus Brielmeier

Objectives

We here assessed whether typical pathogens of laboratory mice affect the development of diet-induced obesity and glucose intolerance, and whether colonization affects the efficacy of the GLP-1R agonist liraglutide and of the GLP-1/GIP co-agonist MAR709 to treat obesity and diabetes.

Methods

Male C57BL/6J mice were experimentally infected with Helicobacter hepaticus, Rodentibacter pneumotropicus and Staphylococcus aureus and compared to a group of uninfected specific and opportunistic pathogen free (SOPF) mice. The development of diet-induced obesity and glucose intolerance was monitored over a period of 26 weeks. To study the influence of pathogens on drug treatment, mice were then subjected for 6 days daily treatment with either the GLP-1 receptor agonist liraglutide or the GLP-1/GIP co-agonist MAR709.

Results

Colonized mice did not differ from SOPF controls regarding HFD-induced body weight gain, food intake, body composition, glycemic control, or responsiveness to treatment with liraglutide or the GLP-1/GIP co-agonist MAR709.

Conclusions

We conclude that the occurrence of H. hepaticus, R. pneumotropicus and S. aureus does neither affect the development of diet-induced obesity or type 2 diabetes, nor the efficacy of GLP-1-based drugs to decrease body weight and to improve glucose control in mice.

目的:我们在此评估了实验室小鼠的典型病原体是否会影响饮食诱导的肥胖和葡萄糖不耐受的发生,以及定植是否会影响 GLP-1R 激动剂利拉鲁肽和 GLP-1/GIP 协同激动剂 MAR709 治疗肥胖和糖尿病的疗效:雄性 C57BL/6J 小鼠通过实验感染了肝螺旋杆菌、肺炎棒状杆菌和金黄色葡萄球菌,并与一组未感染的无特异性和机会性病原体 (SOPF) 小鼠进行了比较。在 26 周的时间里,对饮食引起的肥胖和葡萄糖不耐受的发展情况进行了监测。为了研究病原体对药物治疗的影响,小鼠每天接受 6 天 GLP-1 受体激动剂利拉鲁肽或 GLP-1/GIP 协同激动剂 MAR709 的治疗:结果:定植小鼠在HFD诱导的体重增加、食物摄入量、身体成分、血糖控制、对利拉鲁肽或GLP-1/GIP联合受体激动剂MAR709治疗的反应性等方面与SOPF对照组没有差异:我们得出结论:肝脏螺旋杆菌、肺炎棒状杆菌和金黄色葡萄球菌的存在既不会影响饮食诱导肥胖或 2 型糖尿病的发生,也不会影响基于 GLP-1 的药物降低小鼠体重和改善血糖控制的疗效。
{"title":"Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice","authors":"Margit Wunderlich ,&nbsp;Manuel Miller ,&nbsp;Bärbel Ritter ,&nbsp;Ronan Le Gleut ,&nbsp;Hannah Marchi ,&nbsp;Monir Majzoub-Altweck ,&nbsp;Patrick J. Knerr ,&nbsp;Jonathan D. Douros ,&nbsp;Timo D. Müller ,&nbsp;Markus Brielmeier","doi":"10.1016/j.molmet.2024.101992","DOIUrl":"10.1016/j.molmet.2024.101992","url":null,"abstract":"<div><h3>Objectives</h3><p>We here assessed whether typical pathogens of laboratory mice affect the development of diet-induced obesity and glucose intolerance, and whether colonization affects the efficacy of the GLP-1R agonist liraglutide and of the GLP-1/GIP co-agonist MAR709 to treat obesity and diabetes.</p></div><div><h3>Methods</h3><p>Male C57BL/6J mice were experimentally infected with <em>Helicobacter hepaticus, Rodentibacter pneumotropicus</em> and <em>Staphylococcus aureus</em> and compared to a group of uninfected specific and opportunistic pathogen free (SOPF) mice. The development of diet-induced obesity and glucose intolerance was monitored over a period of 26 weeks. To study the influence of pathogens on drug treatment, mice were then subjected for 6 days daily treatment with either the GLP-1 receptor agonist liraglutide or the GLP-1/GIP co-agonist MAR709.</p></div><div><h3>Results</h3><p>Colonized mice did not differ from SOPF controls regarding HFD-induced body weight gain, food intake, body composition, glycemic control, or responsiveness to treatment with liraglutide or the GLP-1/GIP co-agonist MAR709.</p></div><div><h3>Conclusions</h3><p>We conclude that the occurrence of <em>H. hepaticus</em>, <em>R. pneumotropicus</em> and <em>S. aureus</em> does neither affect the development of diet-induced obesity or type 2 diabetes, nor the efficacy of GLP-1-based drugs to decrease body weight and to improve glucose control in mice.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101992"},"PeriodicalIF":7.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001236/pdfft?md5=5eb33fd2a3fbf2eb99e1d3f861ef6797&pid=1-s2.0-S2212877824001236-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis cathepsin d 对巨噬细胞的降解转移至关重要,而巨噬细胞的降解转移是解决肝纤维化所必需的。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-15 DOI: 10.1016/j.molmet.2024.101989
Paloma Ruiz-Blázquez , María Fernández-Fernández , Valeria Pistorio , Celia Martinez-Sanchez , Michele Costanzo , Paula Iruzubieta , Ekaterina Zhuravleva , Júlia Cacho-Pujol , Silvia Ariño , Alejandro Del Castillo-Cruz , Susana Núñez , Jesper B. Andersen , Margherita Ruoppolo , Javier Crespo , Carmen García-Ruiz , Luigi Michele Pavone , Thomas Reinheckel , Pau Sancho-Bru , Mar Coll , José C. Fernández-Checa , Anna Moles

Background and objectives

Fibrosis contributes to 45% of deaths in industrialized nations and is characterized by an abnormal accumulation of extracellular matrix (ECM). There are no specific anti-fibrotic treatments for liver fibrosis, and previous unsuccessful attempts at drug development have focused on preventing ECM deposition. Because liver fibrosis is largely acknowledged to be reversible, regulating fibrosis resolution could offer novel therapeutical options. However, little is known about the mechanisms controlling ECM remodeling during resolution. Changes in proteolytic activity are essential for ECM homeostasis and macrophages are an important source of proteases. Herein, in this study we evaluate the role of macrophage-derived cathepsin D (CtsD) during liver fibrosis.

Methods

CtsD expression and associated pathways were characterized in single-cell RNA sequencing and transcriptomic datasets in human cirrhosis. Liver fibrosis progression, reversion and functional characterization were assessed in novel myeloid-CtsD and hepatocyte-CtsD knock-out mice.

Results

Analysis of single-cell RNA sequencing datasets demonstrated CtsD was expressed in macrophages and hepatocytes in human cirrhosis. Liver fibrosis progression, reversion and functional characterization were assessed in novel myeloid-CtsD (CtsDΔMyel) and hepatocyte-CtsD knock-out mice. CtsD deletion in macrophages, but not in hepatocytes, resulted in enhanced liver fibrosis. Both inflammatory and matrisome proteomic signatures were enriched in fibrotic CtsDΔMyel livers. Besides, CtsDΔMyel liver macrophages displayed functional, phenotypical and secretomic changes, which resulted in a degradomic phenotypical shift, responsible for the defective proteolytic processing of collagen I in vitro and impaired collagen remodeling during fibrosis resolution in vivo. Finally, CtsD-expressing mononuclear phagocytes of cirrhotic human livers were enriched in lysosomal and ECM degradative signaling pathways.

Conclusions

Our work describes for the first-time CtsD-driven lysosomal activity as a central hub for restorative macrophage function during fibrosis resolution and opens new avenues to explore their degradome landscape to inform drug development.

背景和目的:在工业化国家,肝纤维化导致 45% 的死亡,其特征是细胞外基质 (ECM) 的异常积累。目前还没有针对肝纤维化的特异性抗纤维化治疗方法,以往不成功的药物开发尝试主要集中在防止 ECM 沉积方面。由于肝纤维化在很大程度上被认为是可逆的,因此调节肝纤维化的缓解可提供新的治疗方案。然而,人们对缓解过程中控制 ECM 重塑的机制知之甚少。蛋白水解活性的变化对 ECM 的平衡至关重要,而巨噬细胞是蛋白酶的重要来源。在本研究中,我们评估了巨噬细胞衍生的 cathepsin D(CtsD)在肝纤维化过程中的作用:方法:在人类肝硬化的单细胞 RNA 测序和转录组数据集中鉴定了 CtsD 的表达和相关通路。在新型髓系-CtsD基因敲除小鼠和肝细胞-CtsD基因敲除小鼠中评估了肝纤维化的进展、逆转和功能特征:结果:单细胞RNA测序数据集分析表明,CtsD在人类肝硬化患者的巨噬细胞和肝细胞中均有表达。在新型髓系-CtsD(CtsDΔMyel)和肝细胞-CtsD基因敲除小鼠中评估了肝纤维化的进展、逆转和功能特征。巨噬细胞中的 CtsD 基因缺失会导致肝纤维化加重,而肝细胞中的 CtsD 基因缺失不会导致肝纤维化加重。在纤维化的CtsDΔMyel肝脏中,炎症和母质组蛋白质组特征都被富集。此外,CtsDΔMyel肝巨噬细胞在功能、表型和分泌组学方面都发生了变化,导致了降解表型的转变,造成了体外胶原蛋白I蛋白水解过程的缺陷和体内纤维化缓解过程中胶原蛋白重塑的受损。最后,肝硬化患者肝脏中表达 CtsD 的单核吞噬细胞丰富了溶酶体和 ECM 降解信号通路:我们的工作首次描述了 CtsD 驱动的溶酶体活动是巨噬细胞在纤维化消解过程中恢复功能的中心枢纽,并为探索其降解组景观为药物开发提供信息开辟了新途径。
{"title":"Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis","authors":"Paloma Ruiz-Blázquez ,&nbsp;María Fernández-Fernández ,&nbsp;Valeria Pistorio ,&nbsp;Celia Martinez-Sanchez ,&nbsp;Michele Costanzo ,&nbsp;Paula Iruzubieta ,&nbsp;Ekaterina Zhuravleva ,&nbsp;Júlia Cacho-Pujol ,&nbsp;Silvia Ariño ,&nbsp;Alejandro Del Castillo-Cruz ,&nbsp;Susana Núñez ,&nbsp;Jesper B. Andersen ,&nbsp;Margherita Ruoppolo ,&nbsp;Javier Crespo ,&nbsp;Carmen García-Ruiz ,&nbsp;Luigi Michele Pavone ,&nbsp;Thomas Reinheckel ,&nbsp;Pau Sancho-Bru ,&nbsp;Mar Coll ,&nbsp;José C. Fernández-Checa ,&nbsp;Anna Moles","doi":"10.1016/j.molmet.2024.101989","DOIUrl":"10.1016/j.molmet.2024.101989","url":null,"abstract":"<div><h3>Background and objectives</h3><p>Fibrosis contributes to 45% of deaths in industrialized nations and is characterized by an abnormal accumulation of extracellular matrix (ECM). There are no specific anti-fibrotic treatments for liver fibrosis, and previous unsuccessful attempts at drug development have focused on preventing ECM deposition. Because liver fibrosis is largely acknowledged to be reversible, regulating fibrosis resolution could offer novel therapeutical options. However, little is known about the mechanisms controlling ECM remodeling during resolution. Changes in proteolytic activity are essential for ECM homeostasis and macrophages are an important source of proteases. Herein, in this study we evaluate the role of macrophage-derived cathepsin D (CtsD) during liver fibrosis.</p></div><div><h3>Methods</h3><p>CtsD expression and associated pathways were characterized in single-cell RNA sequencing and transcriptomic datasets in human cirrhosis. Liver fibrosis progression, reversion and functional characterization were assessed in novel myeloid-CtsD and hepatocyte-CtsD knock-out mice.</p></div><div><h3>Results</h3><p>Analysis of single-cell RNA sequencing datasets demonstrated CtsD was expressed in macrophages and hepatocytes in human cirrhosis. Liver fibrosis progression, reversion and functional characterization were assessed in novel myeloid-CtsD (CtsD<sup>ΔMyel</sup>) and hepatocyte-CtsD knock-out mice. CtsD deletion in macrophages, but not in hepatocytes, resulted in enhanced liver fibrosis. Both inflammatory and matrisome proteomic signatures were enriched in fibrotic CtsD<sup>ΔMyel</sup> livers. Besides, CtsD<sup>ΔMyel</sup> liver macrophages displayed functional, phenotypical and secretomic changes, which resulted in a degradomic phenotypical shift, responsible for the defective proteolytic processing of collagen I <em>in vitro</em> and impaired collagen remodeling during fibrosis resolution <em>in vivo</em>. Finally, CtsD-expressing mononuclear phagocytes of cirrhotic human livers were enriched in lysosomal and ECM degradative signaling pathways.</p></div><div><h3>Conclusions</h3><p>Our work describes for the first-time CtsD-driven lysosomal activity as a central hub for restorative macrophage function during fibrosis resolution and opens new avenues to explore their degradome landscape to inform drug development.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101989"},"PeriodicalIF":7.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001200/pdfft?md5=195eb12d948ef506074c6bad3375be3b&pid=1-s2.0-S2212877824001200-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RIPK1 is dispensable for cell death regulation in β-cells during hyperglycemia RIPK1对高血糖时β细胞的细胞死亡调节是不可或缺的。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-14 DOI: 10.1016/j.molmet.2024.101988
Önay Veli , Öykü Kaya , Ana Beatriz Varanda , Ximena Hildebrandt , Peng Xiao , Yann Estornes , Matea Poggenberg , Yuan Wang , Manolis Pasparakis , Mathieu J.M. Bertrand , Henning Walczak , Alessandro Annibaldi , Alessandra K. Cardozo , Nieves Peltzer

Objective

Receptor-interacting protein kinase 1 (RIPK1) orchestrates the decision between cell survival and cell death in response to tumor necrosis factor (TNF) and other cytokines. Whereas the scaffolding function of RIPK1 is crucial to prevent TNF-induced apoptosis and necroptosis, its kinase activity is required for necroptosis and partially for apoptosis. Although TNF is a proinflammatory cytokine associated with β-cell loss in diabetes, the mechanism by which TNF induces β-cell demise remains unclear.

Methods

Here, we dissected the contribution of RIPK1 scaffold versus kinase functions to β-cell death regulation using mice lacking RIPK1 specifically in β-cells (Ripk1β-KO mice) or expressing a kinase-dead version of RIPK1 (Ripk1D138N mice), respectively. These mice were challenged with streptozotocin, a model of autoimmune diabetes. Moreover, Ripk1β-KO mice were further challenged with a high-fat diet to induce hyperglycemia. For mechanistic studies, pancreatic islets were subjected to various killing and sensitising agents.

Results

Inhibition of RIPK1 kinase activity (Ripk1D138N mice) did not affect the onset and progression of hyperglycemia in a type 1 diabetes model. Moreover, the absence of RIPK1 expression in β-cells did not affect normoglycemia under basal conditions or hyperglycemia under diabetic challenges. Ex vivo, primary pancreatic islets are not sensitised to TNF-induced apoptosis and necroptosis in the absence of RIPK1. Intriguingly, we found that pancreatic islets display high levels of the antiapoptotic cellular FLICE-inhibitory protein (cFLIP) and low levels of apoptosis (Caspase-8) and necroptosis (RIPK3) components. Cycloheximide treatment, which led to a reduction in cFLIP levels, rendered primary islets sensitive to TNF-induced cell death which was fully blocked by caspase inhibition.

Conclusions

Unlike in many other cell types (e.g., epithelial, and immune), RIPK1 is not required for cell death regulation in β-cells under physiological conditions or diabetic challenges. Moreover, in vivo and in vitro evidence suggest that pancreatic β-cells do not undergo necroptosis but mainly caspase-dependent death in response to TNF. Last, our results show that β-cells have a distinct mode of regulation of TNF-cytotoxicity that is independent of RIPK1 and that may be highly dependent on cFLIP.

目的受体相互作用蛋白激酶1(RIPK1)在肿瘤坏死因子(TNF)和其他细胞因子的作用下协调细胞存活与细胞死亡之间的决定。RIPK1 的支架功能对防止 TNF 诱导的细胞凋亡和坏死至关重要,而其激酶活性则是坏死和部分细胞凋亡所必需的。方法:在此,我们利用在β细胞中特异性缺乏RIPK1的小鼠(Ripk1β-KO小鼠)或表达激酶死亡版RIPK1的小鼠(Ripk1D138N小鼠),分别研究了RIPK1支架和激酶功能对β细胞死亡调控的贡献。这些小鼠接受了链脲佐菌素(一种自身免疫性糖尿病模型)的挑战。此外,Ripk1β-KO 小鼠还进一步接受高脂饮食以诱发高血糖。为了进行机理研究,对胰岛进行了各种杀灭和致敏试验:结果:抑制 RIPK1 激酶活性(Ripk1D138N 小鼠)不会影响 1 型糖尿病模型中高血糖的发生和发展。此外,β细胞中 RIPK1 的表达缺失不会影响基础条件下的正常血糖或糖尿病挑战下的高血糖。在体内外,原代胰岛细胞在缺乏 RIPK1 的情况下不会对 TNF 诱导的细胞凋亡和坏死敏感。有趣的是,我们发现胰岛显示出高水平的抗凋亡细胞 FLICE 抑制蛋白(cFLIP)以及低水平的凋亡(Caspase-8)和坏死(RIPK3)成分。环己亚胺处理导致 cFLIP 水平下降,使原代胰岛对 TNF 诱导的细胞死亡敏感,而 Caspase 抑制剂可完全阻断 TNF 诱导的细胞死亡:结论:与许多其他类型的细胞(如上皮细胞和免疫细胞)不同,在生理条件或糖尿病挑战下,β细胞的细胞死亡调节并不需要RIPK1。此外,体内和体外证据表明,胰腺β细胞对 TNF 的反应不是坏死,而主要是依赖于 Caspase 的死亡。最后,我们的研究结果表明,β细胞对TNF毒性有一种独特的调节模式,这种模式独立于RIPK1,可能高度依赖于cFLIP。
{"title":"RIPK1 is dispensable for cell death regulation in β-cells during hyperglycemia","authors":"Önay Veli ,&nbsp;Öykü Kaya ,&nbsp;Ana Beatriz Varanda ,&nbsp;Ximena Hildebrandt ,&nbsp;Peng Xiao ,&nbsp;Yann Estornes ,&nbsp;Matea Poggenberg ,&nbsp;Yuan Wang ,&nbsp;Manolis Pasparakis ,&nbsp;Mathieu J.M. Bertrand ,&nbsp;Henning Walczak ,&nbsp;Alessandro Annibaldi ,&nbsp;Alessandra K. Cardozo ,&nbsp;Nieves Peltzer","doi":"10.1016/j.molmet.2024.101988","DOIUrl":"10.1016/j.molmet.2024.101988","url":null,"abstract":"<div><h3>Objective</h3><p>Receptor-interacting protein kinase 1 (RIPK1) orchestrates the decision between cell survival and cell death in response to tumor necrosis factor (TNF) and other cytokines. Whereas the scaffolding function of RIPK1 is crucial to prevent TNF-induced apoptosis and necroptosis, its kinase activity is required for necroptosis and partially for apoptosis. Although TNF is a proinflammatory cytokine associated with β-cell loss in diabetes, the mechanism by which TNF induces β-cell demise remains unclear.</p></div><div><h3>Methods</h3><p>Here, we dissected the contribution of RIPK1 scaffold versus kinase functions to β-cell death regulation using mice lacking RIPK1 specifically in β-cells (<em>Ripk1</em><sup><em>β-KO</em></sup> mice) or expressing a kinase-dead version of RIPK1 (<em>Ripk1</em><sup><em>D138N</em></sup> mice), respectively. These mice were challenged with streptozotocin, a model of autoimmune diabetes. Moreover, <em>Ripk1</em><sup><em>β-KO</em></sup> mice were further challenged with a high-fat diet to induce hyperglycemia. For mechanistic studies, pancreatic islets were subjected to various killing and sensitising agents.</p></div><div><h3>Results</h3><p>Inhibition of RIPK1 kinase activity (<em>Ripk1</em><sup><em>D138N</em></sup> mice) did not affect the onset and progression of hyperglycemia in a type 1 diabetes model. Moreover, the absence of RIPK1 expression in β-cells did not affect normoglycemia under basal conditions or hyperglycemia under diabetic challenges. <em>Ex vivo</em>, primary pancreatic islets are not sensitised to TNF-induced apoptosis and necroptosis in the absence of RIPK1. Intriguingly, we found that pancreatic islets display high levels of the antiapoptotic cellular FLICE-inhibitory protein (cFLIP) and low levels of apoptosis (Caspase-8) and necroptosis (RIPK3) components. Cycloheximide treatment, which led to a reduction in cFLIP levels, rendered primary islets sensitive to TNF-induced cell death which was fully blocked by caspase inhibition.</p></div><div><h3>Conclusions</h3><p>Unlike in many other cell types (e.g., epithelial, and immune), RIPK1 is not required for cell death regulation in β-cells under physiological conditions or diabetic challenges. Moreover, <em>in vivo</em> and <em>in vitro</em> evidence suggest that pancreatic β-cells do not undergo necroptosis but mainly caspase-dependent death in response to TNF. Last, our results show that β-cells have a distinct mode of regulation of TNF-cytotoxicity that is independent of RIPK1 and that may be highly dependent on cFLIP.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101988"},"PeriodicalIF":7.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001194/pdfft?md5=369f13a6e3e4a1b99fd266339f1df0c9&pid=1-s2.0-S2212877824001194-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive alpha, beta, and delta cell transcriptomics reveal an association of cellular aging with MHC class I upregulation 全面的α、β和δ细胞转录组学揭示了细胞衰老与 MHC I 类上调之间的关联。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-14 DOI: 10.1016/j.molmet.2024.101990
W. Staels , C. Berthault , S. Bourgeois , V. Laville , C. Lourenço , N. De Leu , R. Scharfmann

Objectives

This study aimed to evaluate the efficacy of a purification method developed for isolating alpha, beta, and delta cells from pancreatic islets of adult mice, extending its application to islets from newborn and aged mice. Furthermore, it sought to examine transcriptome dynamics in mouse pancreatic endocrine islet cells throughout postnatal development and to validate age-related alterations within these cell populations.

Methods

We leveraged the high surface expression of CD71 on beta cells and CD24 on delta cells to FACS-purify alpha, beta, and delta cells from newborn (1-week-old), adult (12-week-old), and old (18-month-old) mice. Bulk RNA sequencing was conducted on these purified cell populations, and subsequent bioinformatic analyses included differential gene expression, overrepresentation, and intersection analysis.

Results

Alpha, beta, and delta cells from newborn and aged mice were successfully FACS-purified using the same method employed for adult mice. Our analysis of the age-related transcriptional changes in alpha, beta, and delta cell populations revealed a decrease in cell cycling and an increase in neuron-like features processes during the transition from newborn to adult mice. Progressing from adult to old mice, we identified an inflammatory gene signature related to aging (inflammaging) encompassing an increase in β-2 microglobulin and major histocompatibility complex (MHC) Class I expression.

Conclusions

Our study demonstrates the effectiveness of our cell sorting technique in purifying endocrine subsets from mouse islets at different ages. We provide a valuable resource for better understanding endocrine pancreas aging and identified an inflammaging gene signature with increased β-2 microglobulin and MHC Class I expression as a common hallmark of old alpha, beta, and delta cells, with potential implications for immune response regulation and age-related diabetes.

研究目的本研究旨在评估从成年小鼠胰岛中分离α、β和δ细胞的纯化方法的有效性,并将其应用扩展到新生小鼠和老龄小鼠的胰岛。此外,它还试图研究小鼠胰腺内分泌胰岛细胞在整个出生后发育过程中的转录组动态,并验证这些细胞群中与年龄相关的变化:方法:我们利用β细胞表面高表达的CD71和δ细胞表面高表达的CD24,从新生小鼠(1周大)、成年小鼠(12周大)和老龄小鼠(18个月大)的α、β和δ细胞中进行FACS纯化。对这些纯化的细胞群进行了大量 RNA 测序,随后进行了生物信息学分析,包括差异基因表达、过度代表和交叉分析:结果:采用与成年小鼠相同的方法,成功地对新生小鼠和老年小鼠的α、β和δ细胞进行了FACS纯化。我们对α、β和δ细胞群中与年龄相关的转录变化进行的分析表明,在新生小鼠向成年小鼠过渡的过程中,细胞周期减少,神经元样特征过程增加。从成年小鼠到老年小鼠,我们发现了与衰老(炎症老化)有关的炎症基因特征,包括β-2微球蛋白和主要组织相容性复合体(MHC)I类表达的增加:我们的研究证明了细胞分拣技术在纯化不同年龄小鼠胰岛内分泌亚群方面的有效性。我们为更好地了解胰腺内分泌衰老提供了宝贵的资源,并确定了一种炎症基因特征,即β-2微球蛋白和MHC I类表达的增加是老年α、β和δ细胞的共同特征,这对免疫反应调节和年龄相关性糖尿病具有潜在的影响。
{"title":"Comprehensive alpha, beta, and delta cell transcriptomics reveal an association of cellular aging with MHC class I upregulation","authors":"W. Staels ,&nbsp;C. Berthault ,&nbsp;S. Bourgeois ,&nbsp;V. Laville ,&nbsp;C. Lourenço ,&nbsp;N. De Leu ,&nbsp;R. Scharfmann","doi":"10.1016/j.molmet.2024.101990","DOIUrl":"10.1016/j.molmet.2024.101990","url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to evaluate the efficacy of a purification method developed for isolating alpha, beta, and delta cells from pancreatic islets of adult mice, extending its application to islets from newborn and aged mice. Furthermore, it sought to examine transcriptome dynamics in mouse pancreatic endocrine islet cells throughout postnatal development and to validate age-related alterations within these cell populations.</p></div><div><h3>Methods</h3><p>We leveraged the high surface expression of CD71 on beta cells and CD24 on delta cells to FACS-purify alpha, beta, and delta cells from newborn (1-week-old), adult (12-week-old), and old (18-month-old) mice. Bulk RNA sequencing was conducted on these purified cell populations, and subsequent bioinformatic analyses included differential gene expression, overrepresentation, and intersection analysis.</p></div><div><h3>Results</h3><p>Alpha, beta, and delta cells from newborn and aged mice were successfully FACS-purified using the same method employed for adult mice. Our analysis of the age-related transcriptional changes in alpha, beta, and delta cell populations revealed a decrease in cell cycling and an increase in neuron-like features processes during the transition from newborn to adult mice. Progressing from adult to old mice, we identified an inflammatory gene signature related to aging (inflammaging) encompassing an increase in β-2 microglobulin and major histocompatibility complex (MHC) Class I expression.</p></div><div><h3>Conclusions</h3><p>Our study demonstrates the effectiveness of our cell sorting technique in purifying endocrine subsets from mouse islets at different ages. We provide a valuable resource for better understanding endocrine pancreas aging and identified an inflammaging gene signature with increased β-2 microglobulin and MHC Class I expression as a common hallmark of old alpha, beta, and delta cells, with potential implications for immune response regulation and age-related diabetes.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101990"},"PeriodicalIF":7.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001212/pdfft?md5=e0f1edd38415e3ea35a9b982fc29c13e&pid=1-s2.0-S2212877824001212-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alpha-melanocyte-stimulating hormone contributes to an anti-inflammatory response to lipopolysaccharide α-黑色素细胞刺激素有助于雄性 C57BL6/J 小鼠对脂多糖产生抗炎反应。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-09 DOI: 10.1016/j.molmet.2024.101986

Objective

During infection, metabolism and immunity react dynamically to promote survival through mechanisms that remain unclear. Pro-opiomelanocortin (POMC) cleavage products are produced and released in the brain and in the pituitary gland. One POMC cleavage product, alpha-melanocyte-stimulating hormone (α-MSH), is known to regulate food intake and energy expenditure and has anti-inflammatory effects. However, it is not known whether α-MSH is required to regulate physiological anti-inflammatory responses. We recently developed a novel mouse model with a targeted mutation in Pomc (Pomctm1/tm1 mice) to block production of all α-MSH forms which are required to regulate metabolism. To test whether endogenous α-MSH is required to regulate immune responses, we compared acute bacterial lipopolysaccharide (LPS)-induced inflammation between Pomctm1/tm1 and wild-type Pomcwt/wt mice.

Methods

We challenged 10- to 14-week-old male Pomctm1/tm1 and Pomcwt/wt mice with single i.p. injections of either saline or low-dose LPS (100 μg/kg) and monitored immune and metabolic responses. We used telemetry to measure core body temperature (Tb), ELISA to measure circulating cytokines, corticosterone and α-MSH, and metabolic chambers to measure body weight, food intake, activity, and respiration. We also developed a mass spectrometry method to measure three forms of α-MSH produced in the mouse hypothalamus and pituitary gland.

Results

LPS induced an exaggerated immune response in Pomctm1/tm1 compared to Pomcwt/wt mice. Both groups of mice were hypoactive and hypothermic following LPS administration, but Pomctm1/tm1 mice were significantly more hypothermic compared to control mice injected with LPS. Pomctm1/tm1 mice also had reduced oxygen consumption and impaired metabolic responses to LPS compared to controls. Pomctm1/tm1 mice had increased levels of key proinflammatory cytokines at 2 h and 4 h post LPS injection compared to Pomcwt/wt mice. Lastly, Pomcwt/wt mice injected with LPS compared to saline had increased total α-MSH in circulation 2 h post injection.

Conclusions

Our data indicate endogenous α-MSH contributes to the inflammatory immune responses triggered by low-dose LPS administration and suggest that targeting the melanocortin system could be a potential therapeutic for the treatment of sepsis or inflammatory disease.

目的:在感染过程中,新陈代谢和免疫会通过尚不明确的机制动态地促进生存。前黑皮素(POMC)裂解产物在大脑和垂体中产生并释放。其中一种 POMC 裂解产物--α-黑色素细胞刺激素(α-MSH)可调节食物摄入量和能量消耗,并具有抗炎作用。然而,α-MSH 是否是调节生理抗炎反应所必需的,目前尚不清楚。我们最近开发了一种新型小鼠模型,该模型中的 Pomc 基因发生了靶向突变(Pomctm1/tm1 小鼠),从而阻断了调节新陈代谢所需的所有形式的 α-MSH 的产生。为了测试调节免疫反应是否需要内源性 α-MSH,我们比较了 Pomctm1/tm1 和野生型 Pomcwt/wt 小鼠由细菌脂多糖(LPS)诱发的急性炎症:我们给10到14周大的雄性Pomctm1/tm1和Pomcwt/wt小鼠单次静脉注射生理盐水或低剂量LPS(100 μg/kg),并监测免疫和代谢反应。我们使用遥测技术测量核心体温 (Tb),使用 ELISA 测量循环细胞因子、皮质酮和α-MSH,使用代谢室测量体重、食物摄入量、活动量和呼吸量。我们还开发了一种质谱方法来测量小鼠下丘脑和垂体产生的三种形式的α-MSH:结果:与 Pomcwt/wt 小鼠相比,LPS 在 Pomctm1/tm1 小鼠中诱导了一种夸张的免疫反应。在注射 LPS 后,两组小鼠均出现低反应和低体温,但与注射 LPS 的对照组小鼠相比,Pomctm1/tm1 小鼠的低体温程度明显更高。与对照组相比,Pomctm1/tm1 小鼠的耗氧量也减少了,对 LPS 的代谢反应也受损了。与 Pomcwt/wt 小鼠相比,Pomctm1/tm1 小鼠在注射 LPS 后 2 小时和 4 小时的主要促炎细胞因子水平升高。最后,与生理盐水相比,注射 LPS 后 2 小时,Pomcwt/wt 小鼠血液循环中的α-MSH 总量增加:我们的数据表明,内源性α-MSH有助于低剂量 LPS 给药引发的炎症免疫反应,并表明以黑色素皮质素系统为靶点可能是治疗败血症或炎症性疾病的一种潜在疗法。
{"title":"Alpha-melanocyte-stimulating hormone contributes to an anti-inflammatory response to lipopolysaccharide","authors":"","doi":"10.1016/j.molmet.2024.101986","DOIUrl":"10.1016/j.molmet.2024.101986","url":null,"abstract":"<div><h3>Objective</h3><p>During infection, metabolism and immunity react dynamically to promote survival through mechanisms that remain unclear. Pro-opiomelanocortin (POMC) cleavage products are produced and released in the brain and in the pituitary gland. One POMC cleavage product, alpha-melanocyte-stimulating hormone (α-MSH), is known to regulate food intake and energy expenditure and has anti-inflammatory effects. However, it is not known whether α-MSH is required to regulate physiological anti-inflammatory responses. We recently developed a novel mouse model with a targeted mutation in <em>Pomc</em> (<em>Pomc</em><sup>tm1/tm1</sup> mice) to block production of all α-MSH forms which are required to regulate metabolism. To test whether endogenous α-MSH is required to regulate immune responses, we compared acute bacterial lipopolysaccharide (LPS)-induced inflammation between <em>Pomc</em><sup>tm1/tm1</sup> and wild-type <em>Pomc</em><sup>wt/wt</sup> mice.</p></div><div><h3>Methods</h3><p>We challenged 10- to 14-week-old male <em>Pomc</em><sup>tm1/tm1</sup> and <em>Pomc</em><sup>wt/wt</sup> mice with single i.p. injections of either saline or low-dose LPS (100 μg/kg) and monitored immune and metabolic responses. We used telemetry to measure core body temperature (T<sub>b</sub>), ELISA to measure circulating cytokines, corticosterone and α-MSH, and metabolic chambers to measure body weight, food intake, activity, and respiration. We also developed a mass spectrometry method to measure three forms of α-MSH produced in the mouse hypothalamus and pituitary gland.</p></div><div><h3>Results</h3><p>LPS induced an exaggerated immune response in <em>Pomc</em><sup>tm1/tm1</sup> compared to <em>Pomc</em><sup>wt/wt</sup> mice. Both groups of mice were hypoactive and hypothermic following LPS administration, but <em>Pomc</em><sup>tm1/tm1</sup> mice were significantly more hypothermic compared to control mice injected with LPS. <em>Pomc</em><sup>tm1/tm1</sup> mice also had reduced oxygen consumption and impaired metabolic responses to LPS compared to controls. <em>Pomc</em><sup>tm1/tm1</sup> mice had increased levels of key proinflammatory cytokines at 2 h and 4 h post LPS injection compared to <em>Pomc</em><sup>wt/wt</sup> mice. Lastly, <em>Pomc</em><sup>wt/wt</sup> mice injected with LPS compared to saline had increased total α-MSH in circulation 2 h post injection.</p></div><div><h3>Conclusions</h3><p>Our data indicate endogenous α-MSH contributes to the inflammatory immune responses triggered by low-dose LPS administration and suggest that targeting the melanocortin system could be a potential therapeutic for the treatment of sepsis or inflammatory disease.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101986"},"PeriodicalIF":7.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001170/pdfft?md5=3006292fce857c6768c726734e6dfc6d&pid=1-s2.0-S2212877824001170-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency 肝糖激酶调节蛋白和碳水化合物反应元件结合蛋白的衰减可减少ALDOB缺乏症的新生脂肪生成,但不会减轻肝内甘油三酯的积累。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-07-06 DOI: 10.1016/j.molmet.2024.101984
Amée M. Buziau , Maaike H. Oosterveer , Kristiaan Wouters , Trijnie Bos , Dean R. Tolan , Loranne Agius , Brian E. Ford , David Cassiman , Coen D.A. Stehouwer , Casper G. Schalkwijk , Martijn C.G.J. Brouwers

Objective

Stable isotope studies have shown that hepatic de novo lipogenesis (DNL) plays an important role in the pathogenesis of intrahepatic lipid (IHL) deposition. Furthermore, previous research has demonstrated that fructose 1-phosphate (F1P) not only serves as a substrate for DNL, but also acts as a signalling metabolite that stimulates DNL from glucose. The aim of this study was to elucidate the mediators of F1P-stimulated DNL, with special focus on two key regulators of intrahepatic glucose metabolism, i.e., glucokinase regulatory protein (GKRP) and carbohydrate response element binding protein (ChREBP).

Methods

Aldolase B deficient mice (Aldob−/−), characterized by hepatocellular F1P accumulation, enhanced DNL, and hepatic steatosis, were either crossed with GKRP deficient mice (Gckr−/−) or treated with short hairpin RNAs directed against hepatic ChREBP.

Results

Aldob−/− mice showed higher rates of de novo palmitate synthesis from glucose when compared to wildtype mice (p < 0.001). Gckr knockout reduced de novo palmitate synthesis in Aldob−/− mice (p = 0.017), without affecting the hepatic mRNA expression of enzymes involved in DNL. In contrast, hepatic ChREBP knockdown normalized the hepatic mRNA expression levels of enzymes involved in DNL and reduced fractional DNL in Aldob−/− mice (p < 0.05). Of interest, despite downregulation of DNL in response to Gckr and ChREBP attenuation, no reduction in intrahepatic triglyceride levels was observed.

Conclusions

Both GKRP and ChREBP mediate F1P-stimulated DNL in aldolase B deficient mice. Further studies are needed to unravel the role of GKRP and hepatic ChREBP in regulating IHL accumulation in aldolase B deficiency.

目的:稳定同位素研究表明,肝脏新生脂肪生成(DNL)在肝内脂质(IHL)沉积的发病机制中起着重要作用。此外,先前的研究表明,1-磷酸果糖(F1P)不仅是 DNL 的底物,而且还是刺激葡萄糖 DNL 的信号代谢物。本研究旨在阐明 F1P 刺激 DNL 的介质,特别关注肝内葡萄糖代谢的两个关键调节因子,即葡萄糖激酶调节蛋白(GKRP)和碳水化合物反应元件结合蛋白(ChREBP):方法:将以肝细胞 F1P 积累、DNL 增强和肝脏脂肪变性为特征的醛缩酶 B 缺乏小鼠(Aldob-/-)与 GKRP 缺乏小鼠(Gckr-/-)杂交,或用针对肝脏 ChREBP 的短发夹 RNAs 处理:结果:与野生型小鼠(p-/-小鼠(p=0.017)相比,Aldob-/-小鼠从葡萄糖中合成棕榈酸酯的速率更高,但不影响参与 DNL 的酶的肝 mRNA 表达。相反,肝脏 ChREBP 基因敲除可使参与 DNL 的酶的肝脏 mRNA 表达水平正常化,并降低 Aldob-/- 小鼠的 DNL 分数(p 结论:GKRP 和 ChREBP 基因敲除可使参与 DNL 的酶的肝脏 mRNA 表达水平正常化,并降低 Aldob-/- 小鼠的 DNL 分数:GKRP 和 ChREBP 在醛缩酶 B 缺乏小鼠中均介导 F1P 刺激的 DNL。还需要进一步研究,以揭示 GKRP 和肝 ChREBP 在醛缩酶 B 缺乏症中调节 IHL 积累的作用。
{"title":"Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency","authors":"Amée M. Buziau ,&nbsp;Maaike H. Oosterveer ,&nbsp;Kristiaan Wouters ,&nbsp;Trijnie Bos ,&nbsp;Dean R. Tolan ,&nbsp;Loranne Agius ,&nbsp;Brian E. Ford ,&nbsp;David Cassiman ,&nbsp;Coen D.A. Stehouwer ,&nbsp;Casper G. Schalkwijk ,&nbsp;Martijn C.G.J. Brouwers","doi":"10.1016/j.molmet.2024.101984","DOIUrl":"10.1016/j.molmet.2024.101984","url":null,"abstract":"<div><h3>Objective</h3><p>Stable isotope studies have shown that hepatic <em>de novo</em> lipogenesis (DNL) plays an important role in the pathogenesis of intrahepatic lipid (IHL) deposition. Furthermore, previous research has demonstrated that fructose 1-phosphate (F1P) not only serves as a substrate for DNL, but also acts as a signalling metabolite that stimulates DNL from glucose. The aim of this study was to elucidate the mediators of F1P-stimulated DNL, with special focus on two key regulators of intrahepatic glucose metabolism, i.e., glucokinase regulatory protein (GKRP) and carbohydrate response element binding protein (ChREBP).</p></div><div><h3>Methods</h3><p>Aldolase B deficient mice (<em>Aldob</em><sup><em>−/−</em></sup>), characterized by hepatocellular F1P accumulation, enhanced DNL, and hepatic steatosis, were either crossed with GKRP deficient mice (<em>Gckr</em><sup><em>−/−</em></sup>) or treated with short hairpin RNAs directed against hepatic ChREBP.</p></div><div><h3>Results</h3><p><em>Aldob</em><sup><em>−/−</em></sup> mice showed higher rates of <em>de novo</em> palmitate synthesis from glucose when compared to wildtype mice (p &lt; 0.001). <em>Gckr</em> knockout reduced <em>de novo</em> palmitate synthesis in <em>Aldob</em><sup><em>−/−</em></sup> mice (p = 0.017), without affecting the hepatic mRNA expression of enzymes involved in DNL. In contrast, hepatic ChREBP knockdown normalized the hepatic mRNA expression levels of enzymes involved in DNL and reduced fractional DNL in <em>Aldob</em><sup><em>−/−</em></sup> mice (p &lt; 0.05). Of interest, despite downregulation of DNL in response to <em>Gckr</em> and ChREBP attenuation, no reduction in intrahepatic triglyceride levels was observed.</p></div><div><h3>Conclusions</h3><p>Both GKRP and ChREBP mediate F1P-stimulated DNL in aldolase B deficient mice. Further studies are needed to unravel the role of GKRP and hepatic ChREBP in regulating IHL accumulation in aldolase B deficiency.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"87 ","pages":"Article 101984"},"PeriodicalIF":7.0,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001157/pdfft?md5=8bca3a7ecd1cb67473ae86fb175ea89b&pid=1-s2.0-S2212877824001157-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1